GK Wealth Management LLC bought a new position in shares of Centene Corporation (NYSE:CNC – Free Report) in the 2nd quarter, Holdings Channel.com reports. The fund bought 8,024 shares of the company’s stock, valued at approximately $515,000.
Several other large investors also recently bought and sold shares of CNC. GAMMA Investing LLC boosted its stake in shares of Centene by 2.4% in the 2nd quarter. GAMMA Investing LLC now owns 10,674 shares of the company’s stock valued at $685,000 after buying an additional 253 shares during the period. Avior Wealth Management LLC acquired a new stake in Centene in the second quarter valued at approximately $360,000. CoreCap Advisors LLC lifted its stake in Centene by 115.0% in the second quarter. CoreCap Advisors LLC now owns 1,088 shares of the company’s stock worth $70,000 after acquiring an additional 582 shares during the last quarter. Somerset Trust Co acquired a new position in Centene during the 2nd quarter worth approximately $230,000. Finally, Versant Capital Management Inc increased its position in shares of Centene by 112.6% in the 2nd quarter. Versant Capital Management Inc now owns 8,463 shares of the company’s stock valued at $543,000 after purchasing an additional 4,482 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Centene Price Performance
Shares of CNC opened at $63.88 on Wednesday. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $69.36. The stock has a market cap of $31.56 billion, a PE ratio of -6.12, a price-to-earnings-growth ratio of 0.34 and a beta of 1.08. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. The firm has a fifty day moving average price of $64.09 and a 200 day moving average price of $50.55.
Analyst Ratings Changes
A number of equities analysts recently commented on CNC shares. Raymond James Financial set a $75.00 target price on shares of Centene in a research note on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft raised Centene from a “hold” rating to a “buy” rating and lifted their price target for the stock from $53.00 to $80.00 in a report on Wednesday, May 20th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $40.00 price objective on shares of Centene in a research report on Wednesday, April 29th. Robert W. Baird raised their target price on Centene from $46.00 to $66.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. Finally, Cantor Fitzgerald boosted their target price on Centene from $60.00 to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Centene currently has an average rating of “Hold” and a consensus price target of $68.58.
View Our Latest Report on Centene
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
